Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer
Experimental and Toxicologic Pathology · 2016-10 · 68 (9) · 505-515
DOI: 10.1016/j.etp.2016.08.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Toxicologic Pathology, 2016-10. Verfasst von Lauren E Himmel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA; Division of Medicinal Chemi…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS, NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University…
- Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
- Department of Neuroscience, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
- Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA; Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
- Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. Electronic address: kulp.1@osu.edu.
Förderung
- NCATS NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Himmel, L. E., Lustberg, M. B., DeVries, A. C., Poi, M., Chen, C. S., & Kulp, S. K. (2016). Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. Experimental and Toxicologic Pathology, 68(9), 505-515. https://doi.org/10.1016/j.etp.2016.08.001
Vancouver
Himmel LE, Lustberg MB, DeVries AC, Poi M, Chen CS, Kulp SK. Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. Experimental and Toxicologic Pathology. 2016;68(9):505-515. doi:10.1016/j.etp.2016.08.001
BibTeX
@article{Himmel2016,
author = {Himmel, Lauren E and Lustberg, Maryam B and DeVries, A Courtney and Poi, Ming and Chen, Ching-Shih and Kulp, Samuel K},
title = {Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer},
journal = {Experimental and Toxicologic Pathology},
year = {2016},
volume = {68},
number = {9},
pages = {505--515},
doi = {10.1016/j.etp.2016.08.001}
}
EUVIMED